Skip to content
Category

Aldoximes

page 1
pralidoxime
Pralidoxime (2-pyridine aldoxime methyl chloride) or 2-PAM, usually as the chloride or iodide salts, belongs to a family of compounds called oximes that bind to organophosphate-inactivated acetylcholinesterase. It is used to treat organophosphate poisoning in conjunction with atropine and either diazepam or midazolam. It is a white solid.
obidoxime chloride
Obidoxime is a member of the oxime family used to treat organophosphate poisoning. Oximes are drugs known for their ability to reverse the binding of organophosphorus compounds to the enzyme acetylcholinesterase (AChE).
perillartine
Perillartine, also known as perillartin and perilla sugar, is a semisynthetic sweetener that is about 2000 times as sweet as sucrose. It is mainly used in Japan. Perillartine is the oxime of perillaldehyde, which is extracted from plants of the genus Perilla (Lamiaceae).
(EZ)-acetaldehyde oxime
Acetaldoxime is the chemical compound with formula C2H5NO. It is one of the simplest oxime-containing compounds, and has a wide variety of uses in chemical synthesis.
salicylaldoxime
Salicylaldoxime is an organic compound described by the formula . It is the oxime of salicylaldehyde. This crystalline, colorless solid is a chelator and sometimes used in the analysis of samples containing transition metal ions, with which it often forms brightly coloured coordination complexes.
formaldoxime
Formaldoxime is the organic compound with the formula . It is the oxime of formaldehyde. A colorless liquid, the pure compound tends to polymerize into a cyclic trimer. Aqueous solutions are stable as is the formaldoxime hydrochloride (). It is a reagent in organic synthesis for the conversion of aryl diazonium salts to aryl aldehydes.
trimedoxime bromide
chemical compound
milameline
Milameline (CI-979, PD-129,409, RU-35,926) is a non-selective muscarinic acetylcholine receptor partial agonist with cognition-acting properties that was being investigated for the treatment of Alzheimer's disease, but produced poor results in clinical trials and was subsequently discontinued.
Asoxime chloride
chemical compound
benzaldoxime
chemical compound